IDH2 INHIBITORS FOR THE TREATMENT OF HAEMATOLOGICAL MALIGANCIES AND SOLID TUMOURS.

摘要

Provided are methods and compositions for treating cancers in patients carrying an IDH1 mutation or IDH2 mutation.